Table 4.
Clinicopathologic Features of Five Actual 3-Year Survivors with Jaundice
| Age/ Sex |
Peak Bili |
CA 19-9 |
Preoperative Biliary Drainage |
Type of Resection |
Margin | Grade | Stage | LVI | PNI | DFI (mo) |
Adjuvant therapy |
OS (mo) |
Vital Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 52/M | 14.3 | NR | None | Radical Cholecystectomy | R0 | Moderate | T2NX | No | No | 107 | No | 107 | NED |
| 25/M | NR | NR | Percutaneous | Cholecystectomy + CBD resection | R1 | Moderate | TxN1 | No | Yes | 49 | NR | 68.3 | DOD |
| 64/F | NR | 24 | Endoscopic | Radical Cholecystectomy + CBD resection | R1 | Moderate | T3N1 | Yes | No | 18.8 | Yes | 48.9 | DOD |
| 48/M | 6.5 | 31 | Endoscopic | Radical Cholecystectomy | R0 | Poor | T3N1 | No | Yes | 18.2 | No | 40.5 | DOD |
| 67/F | 4.9 | NR | None | Extended Major Hepatectomy + CBD resection | R1 | Poor | T3N1 | No | Yes | 10 | Yes | 38.9 | DOD |
Abbreviations: M=male; F=female; NR=not recorded; CBD= common bile duct; Bili= bilirubin; LVI= lymphovascular invasion; PNI=perineural invasion; DFI= disease free interval; mo=months; Chemo=chemotherapy; RT=radiotherapy; OS=overall survival; CA=carcinoembryonic antigen